Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Chiara Falcomatà, Stefanie Bärthel, Günter Schneider, et al.
Cancer Discovery (2023) Vol. 13, Iss. 2, pp. 278-297
Open Access | Times Cited: 95

Showing 26-50 of 95 citing articles:

Research Developments in Cancer Hallmarks and Immune Checkpoints Based on Mechanisms of Tumour Microenvironment
Chao Jin
Theoretical and Natural Science (2025) Vol. 90, Iss. 1, pp. 38-47
Closed Access
GPR55 in the tumor microenvironment of pancreatic cancer controls tumorigenesis
Dušica Ristić, Thomas Bärnthaler, Eva Gruden, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
A safe haven for cancer cells: tumor plus stroma control by DYRK1B
Miriam Ems, Anna Brichkina, Matthias Lauth
Oncogene (2025)
Open Access
Single-cell transcriptomics analysis reveals dynamic changes and prognostic signature in tumor microenvironment of PDAC
Yongsheng Li, Zhilong Ding, Tao Cheng, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Predictive biomarkers of pancreatic cancer metastasis: A comprehensive review
Mengting Chen, Hongsen Liu, Yufei Xiao, et al.
Clinica Chimica Acta (2025), pp. 120176-120176
Closed Access
Advances in Vaccine-Based Therapies for Pancreatic Cancer
Matthew T. McMillan, Kevin C. Soares
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access
Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Tarık Demır, Carolyn Moloney, Devalingam Mahalingam
Cancers (2025) Vol. 17, Iss. 5, pp. 715-715
Open Access
Advances in diagnostic and therapeutic applications of mismatch repair loss in cancer
J T DeWitt, D Jimenez-Tovar, Aloran Mazumder, et al.
DNA repair (2025) Vol. 147, pp. 103822-103822
Open Access
Self‐Accelerated Nanoregulators for Positive Feedback Ferroptosis‐Immunotherapy
Xu Zhang, Xinlu Zhang, Qin Fan, et al.
Small (2025)
Open Access
The C/EBPβ antagonist peptide lucicebtide (ST101) induces macrophage polarization toward a pro-inflammatory phenotype and enhances anti-tumor immune responses
Claudio Scuoppo, Rick Ramirez, Siok Leong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Yaohui Fang, Chunlu Tan, Zhenjiang Zheng, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116849-116849
Closed Access
Cascading catalytic nanozyme enhance ferroptosis-mediated chemoimmunotherapy via the cGAS-STING and IL-6/STAT3 pathways
Yuxuan Zhao, Guomin Zhang, Feiran Yu, et al.
Chemical Engineering Journal (2025), pp. 161354-161354
Closed Access
Leveraging T cell co-stimulation for enhanced therapeutic efficacy of trispecific antibodies targeting prostate cancer
Yanping Sun, Linling Zhou, Xinyu Gu, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010140-e010140
Open Access
Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer
Alice Carrier, Nadine Abdel Hadi, Gabriela Reyes‐Castellanos, et al.
Research Square (Research Square) (2025)
Open Access
Multidimensional transcriptomics based to illuminate the mechanisms of taurine metabolism in immune resistance of pancreatic cancer
Zongshuai Qin, Gui‐Xiang Huang, Jian Xu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Evaluation of the efficacy and predictive indicators of PD- 1 inhibitors combined with chemotherapy in advanced pancreatic cancer
Tiantian Zhang, Yangyang Zhou, Yue Wu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The acidic microenvironment promotes pancreatic cancer progression via the lncRNA-LOC100507424/E2F1/FOXM1 axis
Di Mu, Ying Shi, Runxuan Sun, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
Yingyan Yu, Wenjie Peng
Cancer Biology and Medicine (2023), pp. 1-16
Open Access | Times Cited: 12
Genetic and other risk factors for pancreatic ductal adenocarcinoma (PDAC)
Michelle F. Jacobs, Elena M. Stoffel
Familial Cancer (2024) Vol. 23, Iss. 3, pp. 221-232
Closed Access | Times Cited: 4
Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associated macrophages recruitment and M2-like polarization
Di Wu, Tiancheng Gong, Zhongxiang Sun, et al.
International Journal of Biological Macromolecules (2024) Vol. 269, pp. 131826-131826
Closed Access | Times Cited: 4
Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancer
Rui Liu, Zhi Ji, Xia Wang, et al.
Investigational New Drugs (2025)
Closed Access
Unlocking the potential of chimeric antigen receptor T cell engineering immunotherapy: Long road to achieve precise targeted therapy for hepatobiliary pancreatic cancers
Hongli Gao, Lianyue Qu, Mu Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 297, pp. 139829-139829
Closed Access
Identification of a novel prognostic marker ADGRG6 in pancreatic adenocarcinoma: multi-omics analysis and experimental validation
Han Wu, Jin Shang, Yuxin Bao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma
Bicheng Ye, Qi Wang, Xiaofeng Zhu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer
Jinglong Guo, Siyue Wang, Qi Gao
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10

Scroll to top